COVID-19 Vaccines – Regulatory Milestones

Milestones :: Perspectives :: Research


COVID-19 Vaccines – Regulatory Milestones


Editor’s Note
Among the critical milestones in the development and regulatory review of candidate COVID-19 vaccines was the meeting earlier this week of the FDA’s Vaccines and Related Biological Products Advisory Committee. We are not aware that any summary report or notes have been released on this meeting but the webcast is now available at the link below. While the meeting runs 08:50 it is critical to appreciating what will come next in the COVID-19 vaccines journey.

FDA – Vaccines and Related Biological Products Advisory Committee 
The Committee met in open session to discuss, in general, the development, authorization and/or licensure of vaccines to prevent COVID-19. No specific application was discussed at this meeting. View webcast